SCHEMBL5907464

SCHEMBL5907464

Cc1cccc(-c2c[nH]nc2-c2ccnc(-c3ccc(OCC(=O)N4CCOCC4)cc3)c2)n1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 9/20 0.49
ALDH1A1 P00352 4/20 0.49
HPGD P15428 2/20 0.49
USP2 O75604 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.45
POLB P06746 1/20 0.45
TGFBR1 P36897 3/20 0.42
ACHE P22303 1/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TSHR P16473 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5907477 0.83 BRD9 (0.45) ALDH1A1HPGDSMN1; SMN2TGFBR1L3MBTL1
SCHEMBL5956366 0.83 FKBP1A (0.47) FKBP1AALDH1A1HPGDUSP2SMN1; SMN2
SCHEMBL5907496 0.81 TGFBR1 (0.56) HPGDTGFBR1
SCHEMBL5907478 0.79 TGFBR1 (0.56) TGFBR1ACHE
SCHEMBL28552520 0.79 TGFBR1 (0.42) TGFBR1
SCHEMBL25085126 0.79 TMEM97 (0.43) FKBP1AALDH1A1HPGDUSP2SMN1; SMN2
SCHEMBL30156238 0.79 TMEM97 (0.43) FKBP1AALDH1A1HPGDUSP2SMN1; SMN2
SCHEMBL23873733 0.79 CYP1A2 (0.44) ALDH1A1HPGDSMN1; SMN2TGFBR1L3MBTL1
SCHEMBL5907473 0.78 TGFBR1 (0.47) TGFBR1
SCHEMBL5907494 0.77 FKBP1A (0.52) FKBP1AALDH1A1HPGDUSP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060058329-A1 Pyrazole inhibitors of the transforming growth factor SMITHKLINE BEECHAM CORPORATION 2006-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058329-A1 Pyrazole inhibitors of the transforming growth factor SMAD3, SMAD2, TGFBR1 FKBP1A 695/4885ALDH1A1 3456/4885HPGD 3693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.